Jessica Koffel

Special Counsel
Full contact info

Experience

Beta Bionics Announces Upsized $234.6 Million IPO, Concurrent $17 Million Private Placement

January 31, 2025

Cooley represented Beta Bionics, a pioneering leader in the development of advanced diabetes management solutions, in its $234.6 million initial public offering and concurrent $17 million private placement.

Read more

Related contacts

Carlos Ramirez
Partner, San Diego
Mark Weeks
Partner, Palo Alto
Charlie Kim
Partner, San Diego
Christine S. Kim
Associate, San Diego
Heidi E. Wang
Associate, San Diego
Alexis Guillermo Buz
Associate, San Diego
Joanna Zhang
Associate, San Diego
Jessica Wade
Paralegal Specialist, San Diego
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Elizabeth Caruso
Associate, New York
Sarah Miller
Associate, New York
Jessica Koffel
Special Counsel, Brussels
Thomas Welk
Senior Counsel, San Diego
Dani Nazemian
Special Counsel, San Diego
Dionne A. Thomas
Associate, San Diego
Ross Eberly
Partner, Santa Monica
Joanna Liebes Hubberts
Partner, San Diego
Chen Chen
Associate, Palo Alto
Alexandra Paterson
Associate, London
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Stephanie Gentile
Partner, New York
Calvin Lee
Associate, New York
Michael Egan
Partner, Washington, DC
Tania Soris
Associate, New York
Rebecca Ross
Special Counsel, Washington, DC
Francis Wheeler
Senior Counsel, Colorado

Related Practices & Industries

Upstream Bio Announces Upsized $293 Million IPO

October 15, 2024

Cooley advised the underwriters of Upstream Bio, a clinical-stage biotech developing a monoclonal antibody to target respiratory disorders, on its upsized $293 million initial public offering.

Read more

Related contacts

Kristin VanderPas
Partner, San Francisco
David Peinsipp
Partner, San Francisco
Denny Won
Partner, San Francisco
Charlie Kim
Partner, San Diego
Claire Keast-Butler
Co-Partner in Charge – London, London
Xander Lee
Partner, Santa Monica
Barbara Mirza
Partner, Santa Monica
Phil Mitchell
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Francis Wheeler
Senior Counsel, Colorado
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Elizabeth Caruso
Associate, New York
Mandy Ching
Associate, London
Megan Drill
Associate, San Diego
Zack Gong
Associate, Shanghai
Peter A. Haddad
Associate, San Diego
David D. Kim
Associate, San Francisco
Jessica Koffel
Special Counsel, Brussels
Sarah Miller
Associate, New York
Lawrence Traylor
Associate, Santa Monica

Related Practices & Industries

Allorion Therapeutics Announces Exclusive Option, Global License Agreement With AstraZeneca

January 2, 2024

Cooley advised Allorion Therapeutics, a US- and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, on its exclusive option and global license agreement with AstraZeneca to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor as a potential new treatment for advanced EGFR-mutant non-small-cell lung cancer.

Read more

Related contacts

Marya Postner
Partner, Palo Alto
Yiming Liu
Partner in Charge – Shanghai, Shanghai
Jameson Davis
Associate, Boston
Xander Lee
Partner, Santa Monica
Sharon Connaughton
Special Counsel, Washington, DC
Rachel Thorn
Partner, New York
Natasha Leskovsek
Of Counsel, Washington, DC
Jessica Koffel
Special Counsel, Brussels
Robert Eisenbach
Of Counsel, San Francisco

Related Practices & Industries

Abivax Announces $235.8 Million IPO

October 20, 2023

Cooley advised Abivax, a clinical-stage biotech company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases, on its $235.8 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Marc Recht
Partner, Boston
Ryan Sansom
Partner, Boston
Denny Won
Partner, San Francisco
Aaron Pomeroy
Partner, Colorado
Richard Segal
Partner, New York
Nyron J. Persaud
Partner, New York
Dr. Madhuri Roy
Partner, Palo Alto
Courtney Thorne
Partner, London
Xander Lee
Partner, Santa Monica
Phil Mitchell
Partner, New York
Stephanie Gentile
Partner, New York
Kevin King
Partner, Washington, DC
Katie Kazem
Partner, Reston
Natasha Leskovsek
Of Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Randy Sabett
Special Counsel, Washington, DC
Reid Hooper
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Minkyu Park
Special Counsel, New York
Jesse Schulman
Associate, Colorado
Barry Kuang
Associate, Boston
Olivia Creser
Associate, New York
Peter A. Haddad
Associate, San Diego
Samuel Paullin
Associate, Chicago
Evan Leitner
Partner, New York
Rick Jantz
Associate, Santa Monica
Cara Buchicchio
Associate, New York
Dr. Jason Valentine
Associate, Washington, DC
Jessica Koffel
Special Counsel, Brussels
Cathy Rude
Paralegal Specialist, Boston

Related Practices & Industries

Turnstone Biologics Announces Upsized $80 Million IPO

July 26, 2023

Cooley advised Turnstone Biologics, a clinical-stage biotechnology company, on its upsized $80 million initial public offering.

Read more

Related contacts

Div Gupta
Partner, New York
Ryan Sansom
Partner, Boston
Lila Hope
Partner, Palo Alto
Valerie Sapozhnikova
Associate, Los Angeles
Julianne Orr
Associate, San Francisco
Anitha Anne
Special Counsel, San Francisco
Cathy Rude
Paralegal Specialist, Boston
Natasha Leskovsek
Of Counsel, Washington, DC
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Tony P. Guan
Associate, Santa Monica
Jessica Koffel
Special Counsel, Brussels
Aaron Pomeroy
Partner, Colorado
Rick Jantz
Associate, Santa Monica
Xander Lee
Partner, Santa Monica
Francis Wheeler
Senior Counsel, Colorado

Related Practices & Industries

View more

Admissions and credentials

Brussels (A List)